Barbara G. Lubejko

Sequences of taxol and cisplatin: a phase I and pharmacologic study.

Eric K. Rowinsky, Mark R. Gilbert, William P. McGuire et al. · Journal of Clinical Oncology · 1991 · 431 citations

Hematological Malignancy, Molecular Pharmacology, Dosage Permutations +15

Phase I and pharmacologic study of topotecan: a novel topoisomerase I inhibitor.

Eric K. Rowinsky, L B Grochow, Carolyn B. Hendricks et al. · Journal of Clinical Oncology · 1992 · 358 citations

Phase I and pharmacological study of the novel topoisomerase I inhibitor 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecin (CPT-11) administered as a ninety-minute infusion every 3 weeks.

Eric K. Rowinsky, L B Grochow, D S Ettinger et al. · PubMed · 1994 · 195 citations

Cpt Analogues, Pharmacotherapy, Metronomic Chemotherapy +16

Phase I and pharmacologic study of paclitaxel and cisplatin with granulocyte colony-stimulating factor: neuromuscular toxicity is dose-limiting.

Eric K. Rowinsky, Vinay Chaudhry, Arlene A. Forastiere et al. · Journal of Clinical Oncology · 1993 · 193 citations

Phase I and Pharmacologic Studies of Topotecan in Patients With Impaired Hepatic Function

Séamus O’Reilly, Eric K. Rowinsky, William J. Slichenmyer et al. · JNCI Journal of the National Cancer Institute · 1996 · 74 citations · Full text